Ocular findings in hepatitis C patients treated with interferon
Mrugacz, M.łg.; Lebensztejn, D.
Klinika Oczna 112(7-9): 253-256
2010
ISSN/ISBN: 0023-2157 PMID: 21121130 Document Number: 644142
The pathology of the liver is associated with many disorders including the eye. We described ocular changes following hepatitis C. The most common ophthalmic findings in hepatitis C patients treated with interferon--involve keratoconjunctivitis, scleritis, dry eye syndrome, uveitis, retinopathy, retinal hemorrhages, anterior ischemic optic neuropathy, retinal vascular changes and macular oedema, as well as electroretinogram, visual field and OCT abnormalities.
Document emailed within 1 workday
Related Documents
Stancek, D.; Fuchsberger, N.; Oltman, M.; Schmeisser, H.; Kontsek, P.; Jahnová, E.; Hajnická, V. 2001: Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2 Acta Virologica 45(5-6): 287-292Sprekeler, R.; Lemmel, E.M.; Obert, H.J. 1990: Correlation of clinical and serological findings in patients with rheumatoid arthritis treated for one year with interferon-gamma Zeitschrift für Rheumatologie 49(1): 1-7
Łapiński, T.W. 2001: Activation of acute phase proteins in patients with chronic hepatitis C treated with interferon-alpha 2a Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 10(57): 138-142
Mauser-Bunschoten, E.P.; Damen, M.; Reesink, H.W.; Roosendaal, G.; Chamuleau, R.A.; van den Berg, H.M. 1996: Formation of antibodies to factor VIII in patients with hemophilia A who are treated with interferon for chronic hepatitis C Annals of Internal Medicine 125(4): 297-299
Daito, K.; Suou, T.; Kawasaki, H. 1994: Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon Research Communications in Chemical Pathology and Pharmacology 83(3): 303-316
Minelli, R.; Coiro, V.; Valli, M.Antonietta.; Finardi, L.; Di Seclì, C.; Bertoni, R.; La Gioia, D.; Barilli, A.Luciana.; Ferrari, C.; Jotti, G.Saccani.; Delsignore, R. 2005: Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection Journal of Investigative Medicine: the Official Publication of the American Federation for Clinical Research 53(1): 26-30
Rocco, A.; Gargano, S.; Provenzano, A.; Nardone, M.; De Sanctis, G.M.; Altavilla, N.; Chircu, L.V.; Grimaldi, F. 2001: Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection Neuro Endocrinology Letters 22(1): 39-44
Czarnywojtek, A.; Waligórska-Stachura, J.; Szczepanek, E.; Zgorzalewicz-Stachowiak, M.łg.; Bereszyńska, I.; Kurdybacha, P.; Stangierski, A.; Harasymczuk, J.; Florek, E.; Waśko, R.; Ruchała, M. 2012: A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine Neuro Endocrinology Letters 33(3): 268-272
Durante-Mangoni, E.; Iardino, P.; Utili, R.; Adinolfi, L.E.; Ruggiero, G. 2006: Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts Antiviral Therapy 11(5): 637-640
Balan, V.; Nelson, D.R.; Sulkowski, M.S.; Everson, G.T.; Lambiase, L.R.; Wiesner, R.H.; Dickson, R.C.; Garcia, A.; Moore, P.A.; Yu, R.; Subramanian, G.M. 2006: Modulation of interferon-specific gene expression by albumin-interferon-alpha in interferon-alpha-experienced patients with chronic hepatitis C Antiviral Therapy 11(7): 901-908
Matsuda, J.; Saitoh, N.; Gotoh, M.; Gohchi, K.; Tsukamoto, M.; Syoji, S.; Miyake, K.; Yamanaka, M. 1995: High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha American Journal of Gastroenterology 90(7): 1138-1141
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Bjøro, K.; Schrumpf, E.; Elgjo, K.; Nordgård, K. 1990: Chronic non-A non-B hepatitis treated with interferon Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(11): 1346-1348
Mels, G.C.; Roffi, L.; Antonelli, G.; Bellati, G.; Pacchetti, S.; Di Nolfo, M.A.; Panizzuti, F.; Moretti, G.; Piperno, A.; Pozzi, M. 1993: Lymphoblastoid interferon in patients with chronic nAnB hepatitis showing relapse during recombinant alpha interferon therapy Progress in Clinical and Biological Research 382: 359-364
Ali, S.; Nazir, G.; Khan, S.A.; Iram, S.; Fatima, F. 2010: Comparative therapeutic response to pegylated interferon plus ribavirin versus interferon alpha-2b in chronic hepatitis C patients Journal of Ayub Medical College Abbottabad: Jamc 22(4): 127-130
Desai, H.G.; Gupte, P.A. 2005: Should acute viral C hepatitis be treated with interferon? Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 24(2): 66-67
Suzuki, H.; Sata, M.; Noguchi, S.; Uchimura, Y.; Tanikawa, K. 1996: Acute hepatitis type C co-infected with GBV-C treated with interferon American Journal of Gastroenterology 91(12): 2651-2652
Danilova, L.V.; Popova, E.V.; Kulakova, O.G.; Tsareva, E.I.; Favorov, A.V.; Favorova, O.O.; Boĭko, A.N. 2014: The activation of the type i interferon signaling pathway in multiple sclerosis patients treated with russian analogue of Β-interferon-1b: transcriptome profiling data Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(2 Part 2): 72-77
Hrycewycz, N.; Sandres, K.; Barange, K.; Pascal, J.P.; Izopet, J.; Payen, J.L. 2001: Eradication of hepatitis C virus after 3 months of interferon and ribavirin treatment in an a interferon non-responder patient with chronic hepatitis C Gastroenterologie Clinique et Biologique 25(11): 1041-1042
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211